Currently Viewing:
COA 2017-ONCOLOGY PAYMENT REFORM
How Has the OCM Evolved? Year 1 Provider Updates
October 24, 2017
Will 2-Sided Risk Be a Reality in OCM?
October 24, 2017
Dr Lucio Gordan: How Practices and Payers Work Together to Implement OCM
October 24, 2017
Dr Jeff Patton Highlights Challenges Encountered With Implementing OCM
October 24, 2017
Physicians Need Clearer Metrics Before Taking on 2-Sided Risk
October 25, 2017
Currently Reading
Terrill Jordan: Education and Data Are Key for OCM Success
October 25, 2017
Stakeholders Weigh-in on Payment Reform in Cancer Care
October 25, 2017
Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug Pricing
November 05, 2017
Dr Ira Klein on Pharmaceutical Interest in Alternative Payment Models
December 07, 2017
Dr Lucio Gordan: Improving Population Health Through Alternative Payment Models
December 08, 2017
Terrill Jordan: Year 1 Feedback on OCM
December 22, 2017
Sarah Cevallos: Physicians Need More Data to Determine if 2-Sided Risk is Appropriate
December 26, 2017
Terrill Jordan Discusses Making Refinements in Year 2 of OCM
January 03, 2018
Judy Berger on What Southwest Airlines Is Doing in Oncology
January 04, 2018
Bo Gamble on COA's Role in 2018
January 05, 2018
Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer Care
January 07, 2018
Dr Roger Brito: What Patients Should Know About Alternative Payment Models, OCM
January 09, 2018
Sarah Cevallos on Her Advice for Practices Looking to Participate in OCM
January 10, 2018
Dr Peter Aran on Involving Providers in Development Process of New Reimbursement Models
January 11, 2018
Dr Jeff Patton Discusses Preparing for OCM, Seeing Improved Outcomes and Savings
January 12, 2018
David Merrill and John Robinson Discuss Barriers to APMs, Factors of Interest
January 15, 2018
Dr Mark Fendrick: Setting Cost-Sharing Based on Value, Not Price, in Cancer Care
January 18, 2018
Terrill Jordan Discusses the Process of Customizing an EMR to Adapt to OCM
January 19, 2018
Dr Roger Brito Discusses Implementing Alternative Payment Models and Its Challenges
January 20, 2018

Terrill Jordan: Education and Data Are Key for OCM Success

Education is key to succeed in the Oncology Care Model, but presenting data in a simple format for clinicians to use is also critical, said Terrill Jordan, CEO, of Regional Cancer Care Associates.


Education is key to succeed in the Oncology Care Model, but presenting data in a simple format for clinicians to use is also critical, said Terrill Jordan, CEO, of Regional Cancer Care Associates.

Transcript

What are some best practices for implementing OCM?

Our best practices have been the education of our clinicians. You have to consistently educate, educate, educate. We also learned that the data was important. Being able to get data and take that data and make it simple in very simple dashboards, we have clinicians who work anywhere from 12- to 15-hour days, their staff is stretch thin, they don’t a lot of time to go through lots of data, so you have to simplify it so they can spend their time focused on just what they need so they can get back to their patients.

We do find that the data is what they’re looking for. They find it enlightening, and sometimes surprising. And it’s always exciting to see how they respond to it.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up